US Patent Issued to MEDIGENE IMMUNOTHERAPIES on June 17 for "Inducible T cell receptors and uses thereof" (German Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,095, issued on June 17, was assigned to MEDIGENE IMMUNOTHERAPIES GMBH (Planegg-Martinsried, Germany).

"Inducible T cell receptors and uses thereof" was invented by Slavoljub Milosevic (Munich), Adriana Turqueti Neves (Olching, Germany), Kristina Schoedel (Munich) and Alexander Schmidt (Zangberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Combinations comprising one or more nucleic acid molecules comprising a nucleic acid sequence A encoding for a TCR alpha chain linked to a dimerization domain, and a nucleic acid sequence B encoding for a TCR beta chain linked to a dimerization domain, as well as proteins encoded by such nucleic acid mol...